Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis

Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis

Biologic medications are recent advances that have clinical significance in the treatment of moderate-to-severe AD. A systemic literature review was performed to examine the efficacy and safety of biologic therapies currently in phase II and phase III of clinical trials for moderate-to-severe AD. Ou...

Full description

Bibliographic Details
Main Authors: Shelley K. Uppal, Donovan G. Kearns, Vipawee S. Chat, George Han, Jashin J. Wu
Format: Article
Language:English
Published: Taylor & Francis Group 2022-02-01
Series:Journal of Dermatological Treatment
Subjects:
biological products/therapeutic use
systemic therapy
biologic therapy
immunotherapy
atopic dermatitis
eczema
Online Access:http://dx.doi.org/10.1080/09546634.2020.1775775

Internet

http://dx.doi.org/10.1080/09546634.2020.1775775

Similar Items